Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches.
Ontology highlight
ABSTRACT: Systemic sclerosis (SSc) is a systemic, immune-mediated chronic disorder characterized by small vessel alterations and progressive fibrosis of the skin and internal organs. The combination of a predisposing genetic background and triggering factors that causes a persistent activation of immune system at microvascular and tissue level is thought to be the pathogenetic driver of SSc. Endothelial alterations with subsequent myofibroblast activation, excessive extracellular matrix (ECM) deposition, and unrestrained tissue fibrosis are the pathogenetic steps responsible for the clinical manifestations of this disease, which can be highly heterogeneous according to the different entity of each pathogenic step in individual subjects. Although substantial progress has been made in the management o
SUBMITTER: Benfaremo D
PROVIDER: S-EPMC8773282 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA